Anticancer Treatment of Breast Cancer Related to Cardiotoxicity and Dysfunctional Endothelium

Plain-language summary

This study investigated the toxic effects of chemotherapy for breast cancer on the heart and the function of the inner lining of blood vessels (endothelium) using various measurements. It enrolled women referred for adjuvant chemotherapy for operable, non-metastatic breast cancer. It was conducted as a non-phase study and has been completed.

The summary above is a plain-language rendering of the official record. The original English title is shown for reference.

Trial details

Phase

Not Applicable

Status

Completed

Sponsor

University of Aarhus

Intervention

Venous occlusion plethysmography, SphygmoCor, 24hour blood pressure, DEXA scan, Laboratory blood samples

Start date

9/1/2015

Estimated completion

6/1/2018

Countries

Denmark

Related genes

Locations

• Aarhus, Denmark

Eligibility criteria

Criteria are reproduced from the ClinicalTrials.gov record in the original English. Only the trial team can determine eligibility.

Inclusion Criteria:

* women referred to receive adjuvant chemotherapy for primary operable non-metastatic breast cancer

Exclusion Criteria:

* former og actual use of cytostatics
* pregnancy